Co-Diagnostics, Inc. Company Description: Founded in 2013 on the principle of making affordable PCR tests available worldwide, Co-Dx™ is a molecular diagnostics provider with unique, patented technology which enables the design of high performing, cost-effective PCR for infectious diseases, at-home/point-of-care, SNP detection, vector surveillance, liquid biopsy and more. Visit us at the 5th Annual Infectious Diseases and Molecular Diagnostic Conference to see how were making our revolutionary Co-Primer™ technology available around the world.
Our vision is to reduce illness and death associated with fungal disease globally; through use of rapid diagnostic testing and targeted, appropriate use of antimicrobials. Our novel and reliable rapid-diagnostic tests fit seamlessly into current treatment pathways, with the aim of reducing the rate of drug resistant infections by promoting a new diagnostic led approach. We aim to achieve this whilst delivering clear financial and clinical benefits to hospitals, clinicians and patient care.
Eurobio Scientific is a major player in the field of specialty in vitro diagnostics products, supplying into the diagnostics, research, transplantation, immunology, and infectious diseases, and industrial laboratories, including pharmaceutical and biotechnology companies.
Eurobio Scientific acquired Surrey based Pathway Diagnostics Ltd in 2019. Pathway Diagnostics Ltd have been supplying haemostasis, immunology, quality control materials and infectious disease products as a distributor and manufacturer to the UK and Ireland IVD, research, and industrial markets since 1998
.png)
Randox Laboratories has established itself as a leading diagnostics developer for laboratories of all sizes. Our Qnostics' molecular IQC portfolio caters to the diverse needs of molecular diagnostics and Nucleic Acid Testing (NAT) laboratories. With a wide range of viral, bacterial, and fungal targets, it ensures precise and reliable testing, boosting lab performance and result confidence.
Randox Qnostics' molecular IQC portfolio guarantees accurate outcomes, empowering labs worldwide.
For more information, visit www.randox.com or contact [email protected].
R-Biopharm Rhône is the UK subsidiary of the R-Biopharm Group, a leading manufacturer of solutions for clinical diagnostics. Including recently acquired AusDiagnostics, we offer a wide range of products for multiple applications including Gastroenterology, AMR, Respiratory Pathogens and Sexual Health. Offering solutions covering Molecular multiplexed syndromic testing , Rapid lateral flow and ELISA based assays our trademark brands such as TandemPlex®, RIDA®GENE and RIDA®QUICK are recognised around the world for providing reliable and quality results.
Abingdon Health is a global rapid diagnostics specialist focused on developing, manufacturing, and commercialising lateral flow immunoassay tests and reader systems in the UK with over 20 years of experience working with customers across all industries including healthcare, plant & animal health, environmental, bio-security and agri-food.
Best-in-class environmentally controlled, UK development & manufacturing facilities.
Automated manufacturing: >100m device annual capacity devices with flexibility to grow.
Full-service range of bespoke services to get your product to market efficiently, including global regulatory consultancy support.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com
Pro-Lab Diagnostics are pleased to support the 5th Annual Infectious Diseases and Molecular Diagnostics Congress. We will have details of our extensive range of Viasure Molecular products and associated automation, and of course our range of rapid diagnostic kits and reagents for Microbiology. We look forward to seeing you there.
AccuBio is a UK-based IVD company, wholly owned by Zhejiang Orient Gene, focussed on delivering rapid, cost-effective diagnostic solutions to expedite clinical management, improve outcomes and promote equitable access to healthcare. In addition to our extensive infectious disease lateral flow test menu, for near-patient or self-testing, and comprehensive drugs of abuse test portfolio, our VISITECT® CD4 Advanced Disease test is a unique semi-quantitative lateral flow test to support the identification of Advanced HIV Disease.
Biofortuna is a specialist contract assay development and manufacturing organisation providing a flexible and scalable outsourcing service to the diagnostic sector’s leading in-vitro and point-of-care assay developers. Operating from state-of-the-art, humidity-controlled premises, and benefiting from ISO 13485 certification, ISO 17025 accreditation and FDA registration, they have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.
EUROIMMUN UK supplies the healthcare industry with medical diagnostic products in the following principal areas: Autoimmunity, Infectious Serology and Allergy.
EUROIMMUN UK is the British subsidiary of the EUROIMMUN Group, which is one of the world’s leading manufacturers of medical laboratory diagnostic products. Diagnostic test systems are offered alongside fully automated instruments and IT solutions. Coupled with the International Training Centre, Reference Laboratory and Institute for Quality Assurance, EUROIMMUN is proud to offer exemplary service and support.
